Skip to main content
. 2023 Apr 28;15(5):1351. doi: 10.3390/pharmaceutics15051351

Figure 2.

Figure 2

Figure 2

Summary of risk-of-bias assessment [21,22,23,24,25,26,27,28,29,30,31].